Cytoxan
Cytoxan
- In Canada and other regulated markets cytoxan (cyclophosphamide) is classified as prescription-only and is normally dispensed via hospital pharmacies, oncology clinics or retail pharmacies; some online or unregulated sellers and a few pharmacies may offer it without a prescription or receipt — this is unsafe and not recommended.
- Cytoxan is used to treat cancers (lymphoma, breast, ovarian and others), certain autoimmune diseases and nephrotic syndrome; it is an alkylating agent (nitrogen mustard analogue) that is metabolized in the liver to active metabolites which cross-link DNA and inhibit cell replication and immune cells.
- Typical doses vary by indication: oncology regimens commonly use IV 300–600 mg/m² per cycle (schedules vary); for autoimmune or nephrotic syndrome oral dosing is often 1–2.5 mg/kg/day (children: commonly 2–2.5 mg/kg/day for 8–12 weeks); dosing must be individualized by a specialist.
- Administration routes include oral tablets or capsules (25 mg, 50 mg), IV infusion or injection after reconstitution (powder vials) and ready-to-use IV solutions in hospital settings.
- Onset of pharmacologic action is rapid after IV administration (drug and metabolites appear in plasma quickly), but clinical benefits (tumour response or immunosuppression) usually take days to weeks to become apparent; hematologic effects (neutropenia) typically appear within about 7–14 days.
- Plasma half-life is approximately several hours (commonly cited ~3–12 hours for parent drug), but therapeutic and toxic effects (immunosuppression, bone marrow suppression) can last days to weeks and cumulative toxicity may persist with repeated dosing.
- Avoid alcohol while on cytoxan — alcohol can worsen nausea, dehydration and may increase liver stress and other side effects; discuss alcohol use with your treating clinician.
- The most common side effec is nausea.
- Would you like to try cytoxan without a prescription?
Basic Cytoxan Information
- INN (International Nonproprietary Name): Cyclophosphamide
- Brand Names Available In Canada (English): Procytox — tablets (25 mg, 50 mg) and injection vials.
- ATC Code: L01AA01 — Alkylating agents, nitrogen mustard analogues.
- Forms & Dosages: Tablets 25 mg and 50 mg for oral administration; capsules commonly 25 mg and 50 mg; powder for solution commonly in 500 mg and 1 g vials for IV reconstitution; ready-to-use IV solutions vary by product.
- Manufacturers In Canada (English): Procytox (Pfizer subsidiary) is listed for Canadian supply.
- Registration Status In Canada (English): Health Canada approval for oncologic and nephrology indications; prescription-only (Rx).
- OTC / Rx Classification: Prescription only (Rx) in Canada.
Instructions, Warnings And Daily-Life Integration
Patients often worry how cytotoxic drugs fit into a normal life and what rules actually matter.
Cytoxan (cyclophosphamide) is a prescription-only cytotoxic medicine regulated by Health Canada and must be handled according to institutional and provincial guidance.
Always ask your prescriber and pharmacist for the Drug Identification Number (DIN) on the package and keep that DIN in your medication record.
Avoid pregnancy and breastfeeding during treatment and follow contraception guidance from your oncology or nephrology team.
If you have an active infection, severe bone marrow suppression, or urinary outflow obstruction, cyclophosphamide is contraindicated per product labels.
For accidental exposure to tablets or vials, follow hospital chemotoxic spill guidelines and contact your provincial poison control centre immediately (for example, the Ontario Poison Centre).
- Emergency Contacts Checklist — Provincial poison control number; your oncology/nephrology clinic; local emergency department; pharmacy phone and DIN recorded.
- Contraception Timeline Checklist — Confirm negative pregnancy test before start; use reliable contraception during treatment; follow specialist advice on how long to avoid conception after stopping (documented in your chart).
- Spill Procedure Checklist — Isolate area; wear PPE; follow institutional chemotoxic spill protocol; call poison control and occupational health.
Plan dosing with predictable routines and bring an up-to-date medication list to every appointment.
In rural areas, order with advance notice from hospital pharmacies or large community chains such as Shoppers Drug Mart or London Drugs.
Cross-border price comparisons are sometimes done, but ensure a Canadian-authorized product with a Health Canada DIN and a valid Canadian prescription before purchasing.
Check provincial plans such as Ontario Drug Benefit, BC PharmaCare, or RAMQ for coverage and prior-authorization requirements.
Everyday Use And Best Practices
Morning Vs Evening Dosing In Canadian Routines
Many patients ask whether to take cyclophosphamide in the morning or at night.
Oral cyclophosphamide tablets (25 mg and 50 mg) can be scheduled to fit daily habits and clinic availability.
Many Canadian patients prefer morning dosing so side effects such as nausea or fatigue can be monitored during clinic hours.
If nausea is prominent, evening dosing may help because sleep can blunt initial symptoms.
For IV pulse dosing, follow the infusion centre schedule; these are commonly every 2–4 weeks in oncology programs and vary for nephrology protocols.
Taking With Or Without Meals (Canadian Diet Context)
Cyclophosphamide may be taken with or without food according to the product monograph and prescriber advice.
A light, low-fat snack before a dose often reduces nausea risk.
Examples of familiar Canadian breakfast items that work well include toast, plain yogurt, or a small bowl of porridge.
Avoid grapefruit products only if your prescriber or pharmacist specifically advises this for a given interaction.
Maintain regular hydration through the day to reduce the risk of bladder irritation and hemorrhagic cystitis.
Follow MESNA protocols where prescribed for uroprotection when receiving high-dose IV regimens.
Dosing Tools And Checklists
- Pillbox And Reminder Tips — Use a weekly pillbox and smartphone alarms for oral cyclophosphamide tablets.
- Clinic Coordination — Keep infusion appointments and bring a printed medication list with DINs to each visit.
- Bilingual Labelling — Request French-English labels in Quebec and any bilingual counselling required.
| Timing | Pros | Cons |
|---|---|---|
| Morning | Side effects monitored during the day; easier to schedule workday clinic visits. | May cause daytime fatigue for some people. |
| Evening | Can sleep through immediate nausea; may suit those working during the day. | Side effects may disturb sleep; less immediate medical supervision if problems arise. |
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Health Canada–approved labeling lists absolute contraindications for cyclophosphamide.
Absolute contraindications include known hypersensitivity to cyclophosphamide or excipients, severe bone marrow suppression, urinary outflow obstruction, and active severe infections.
Pregnancy and breastfeeding are contraindications; confirm negative pregnancy test and document reliable contraception before starting.
Inform the care team about prior radiation, prior chemotherapy, or existing liver or renal impairment as dose adjustments may be necessary.
Activities To Limit (Driving, Workplace Safety)
Cyclophosphamide can cause dizziness, fatigue, and acute nausea which may impair driving or the operation of heavy machinery.
Avoid driving or operating heavy equipment until you know how the medicine affects you.
For those whose work requires sustained alertness, like commercial drivers or machinery operators, discuss restrictions with occupational health and get documentation if required.
Do not crush tablets at home and avoid handling broken tablets; hazardous-waste disposal rules apply for unused cytotoxic medication.
Ask your pharmacy about take-back programs offered by many community chains and hospitals for safe disposal.
- Pre-Treatment Screening Checklist — CBC baseline, creatinine, LFTs, pregnancy test (if applicable), and review of current medications.
- Activity Restrictions Summary — Avoid driving until effects are known; follow workplace guidance for hazardous medication exposure and handling.
Keep an emergency list with your oncology clinic number, local emergency department, and provincial poison control contact.
Dosage And Adjustments
General Regimen (DIN References)
Cyclophosphamide dosing varies by indication and patient characteristics.
Typical oncology IV dosing examples include 300–400 mg/m² every 7–10 days or higher doses such as 600 mg/m² when used in certain breast or ovarian cancer regimens.
For paediatric nephrotic syndrome, the usual oral course is 2–2.5 mg/kg/day for 8–12 weeks.
Tablets in Canada commonly come in 25 mg and 50 mg strengths, and branded Procytox is available domestically; record the DIN from the blister or vial when documenting treatment.
Special Cases (Elderly, Comorbidities)
Elderly patients often require dose reductions guided by renal function and comorbid conditions because myelosuppression risk increases with age.
Renal impairment typically requires dose reduction or longer intervals between doses; severe renal or hepatic impairment requires specialist-led individualization.
Monitor full blood counts frequently and adjust dosing according to trends and specialist instructions.
| Indication | Typical Dose | Monitoring |
|---|---|---|
| Lymphoma | 300–400 mg/m² IV every 7–10 days | CBC before each cycle, renal and hepatic panels |
| Breast/Ovarian Cancer | Part of multidrug regimens; examples include 600 mg/m² IV | Cumulative dose tracking, CBC, organ function tests |
| Nephrotic Syndrome (Children) | 2–2.5 mg/kg/day orally × 8–12 weeks | CBC and renal function during treatment |
Before starting, confirm DIN and check provincial coverage through ODB, PharmaCare, or RAMQ as needed.
User Testimonials
Positive Reports From Canadian Patients
“The drug helped control my child’s nephrotic relapse within weeks, and the hospital pharmacist at the paediatric centre explained the tablets clearly.”
Patients often report meaningful tumour shrinkage when cyclophosphamide is part of combination chemotherapy.
Many praise coordinated care at regional cancer centres and hospital pharmacies such as Sunnybrook and St. Paul’s for improving adherence and counselling.
In Quebec, bilingual labelling and pharmacist counselling at community chains often improve confidence in taking cyclophosphamide tablets.
Common Challenges In Forums
Online discussions on Reddit Canada and provincial health boards highlight common side effects such as nausea, hair loss, urinary irritation, and concerns about fertility.
Access barriers mentioned frequently include distance to infusion centres for rural patients and delays for provincial coverage approvals.
Patients recommend advance scheduling with local pharmacies like Shoppers Drug Mart, Rexall, or London Drugs and using patient navigator services when available.
- Questions To Ask Your Care Team — What is my DIN? Is MESNA or hydration required? What fertility preservation options are available? What coverage authorizations are needed?
- Urban Vs Rural Access — Urban: faster access to infusion centres and hospital pharmacies; Rural: plan for travel and order supplies in advance from community chains or hospital pharmacy.
Buying Guide
Pharmacy Sources
In Canada, cyclophosphamide for IV use is usually prepared and dispensed by hospital pharmacies and infusion centres.
Oral tablets may be dispensed by community pharmacies when prescribed for outpatient use.
Large chains such as Shoppers Drug Mart, Rexall, London Drugs, and Quebec’s Jean Coutu can often order Procytox or generics but may require hospital prescription routing.
Price Comparison (In-Store Vs Online, Cross-Border Notes)
Check provincial formularies for potential coverage under programs like Ontario Drug Benefit, BC PharmaCare, or RAMQ before ordering privately.
Community pharmacies may offer faster local pickup, while hospital or specialty compounding pharmacies handle vials and IV preparations.
Cross-border purchases carry risk; always confirm Health Canada approval, a Canadian DIN, and a valid Canadian prescription if considering importation.
In our online pharmacy, cytoxan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
| Pharmacy | What They Dispense | Notes |
|---|---|---|
| Shoppers Drug Mart | Oral tablets by prescription | Can coordinate orders; call ahead for stock |
| Rexall | Oral tablets by prescription | Community pickup and counselling |
| London Drugs | Oral tablets and coordination with hospitals | Rural-friendly ordering with notice |
| Jean Coutu (Quebec) | Oral tablets; bilingual labelling | Handles provincial paperwork for RAMQ |
When comparing price, request the DIN, check brand versus generic costs, and verify provincial reimbursement criteria.
What’s Inside And How It Works
Ingredients Overview
The active ingredient is cyclophosphamide (INN).
Oral tablets in Canada commonly come as 25 mg and 50 mg strengths, marketed as Procytox and as generics.
Injectable forms are supplied as powder vials (commonly 500 mg or 1 g) to be reconstituted for IV use.
Excipients vary by manufacturer; always check the package insert and DIN to screen for allergies.
Mechanism Basics
Cyclophosphamide is an alkylating agent that requires hepatic activation to form alkylating metabolites.
These metabolites cross-link DNA and prevent cell division, leading to death of rapidly dividing cells such as cancer cells and overactive immune cells.
This mechanism explains both therapeutic effects and common toxicities, including myelosuppression and effects on mucous membranes and fertility.
| Formulation | Strengths | Handling Precautions |
|---|---|---|
| Oral Tablets | 25 mg, 50 mg | Store at room temperature 20–25°C; avoid crushing tablets at home |
| Injectable Powder | 500 mg, 1 g vials (typical) | Reconstitute in hospital; handle as cytotoxic; refrigeration after reconstitution may be required |
Follow hazardous-waste and cytotoxic-handling guidance for disposal and transport.
Main Indications
Approved Uses In Canada
Health Canada approvals cover oncologic uses and nephrology indications such as steroid-resistant nephrotic syndrome.
Oncology regimens commonly use IV cycles, for example 300–400 mg/m² every 7–10 days or as part of multi-drug regimens including doses around 600 mg/m² for some breast and ovarian cancer protocols.
Paediatric nephrotic syndrome regimens include oral dosing of 2–2.5 mg/kg/day for 8–12 weeks.
Off-Label Uses By Canadian Physicians
Off-label uses may include severe autoimmune conditions such as systemic lupus erythematosus or vasculitis and induction therapy in transplant-related conditioning, guided by specialty society recommendations.
Off-label prescribing requires detailed informed consent discussing fertility risks and long-term secondary malignancy risk.
| Indication | Typical Dose | Monitoring |
|---|---|---|
| Lymphoma | 300–400 mg/m² IV q7–10d | CBC each cycle; organ function testing |
| Breast/Ovarian Cancer | Part of combination regimens | Cumulative dose tracking; CBC and LFTs |
| Steroid-Resistant Nephrotic Syndrome | 2–2.5 mg/kg/day oral × 8–12 weeks (paediatric example) | CBC, renal function monitoring |
- Consent Checklist — Discuss fertility preservation options, contraception, expected side effects, and long-term risks before starting.
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
There are no major dietary prohibitions specifically required for cyclophosphamide beyond standard safe practices.
Avoid heavy alcohol intake during treatment because it can worsen nausea and add liver stress.
Caffeine is not directly contraindicated but may worsen dehydration; maintain good hydration to reduce bladder risk.
Grapefruit interactions are uncommon but check with a pharmacist if there is concern about a specific product or excipient.
Drug Conflicts (Health Canada Database)
Cyclophosphamide requires hepatic activation, so strong CYP inducers or inhibitors could theoretically alter activation rates and effects.
Concurrent use of other nephrotoxic agents, potent bone-marrow-suppressing drugs, or live vaccines is generally contraindicated or requires specialist input.
Use Health Canada’s interaction resources or your pharmacy’s interaction checker for a patient-specific review.
| High-Risk Drug Classes | Why Caution Is Needed |
|---|---|
| Other Cytotoxics | Increased myelosuppression risk; requires close CBC monitoring |
| Strong CYP Modifiers | May change hepatic activation rates and efficacy/toxicity balance |
| Live Vaccines | Immune suppression may make live vaccines unsafe or ineffective |
Tell your provider if you take anticoagulants, nephrotoxic drugs, herbal products, or any other prescription medications.
Latest Evidence And Insights
Recent trials and guideline updates continue to define cyclophosphamide’s role in combination chemotherapy and in steroid-resistant nephrotic syndrome.
Canadian centres contribute registry and cohort data on fertility preservation and long-term secondary malignancy risk after cyclophosphamide exposure.
Comparative work highlights differences between IV pulse regimens and continuous oral dosing in autoimmune indications with varied toxicity profiles.
| Study Type | Focus | Practice Impact |
|---|---|---|
| Randomized/Observational | Oncology combination regimens | Supports continued use as backbone alkylator in many protocols |
| Cohort/Registry | Fertility and secondary cancer outcomes | Encourages dose-limiting strategies and fertility counselling |
| Comparative Trials | IV pulse vs oral continuous in autoimmune disease | Helps tailor regimen choice according to toxicity and efficacy balance |
Practice-changing trends include efforts to reduce cumulative dose, routine use of uroprotectants like MESNA for high-dose IV therapy, and improved fertility referral pathways.
Alternative Choices
When cyclophosphamide is not suitable, other alkylating agents may be considered depending on the indication.
Alternatives include ifosfamide, chlorambucil, melphalan, and bendamustine, each with different administration routes and toxicity profiles.
| Agent | Common Use | Main Toxicities |
|---|---|---|
| Ifosfamide | Similar tumour types as cyclophosphamide | Requires MESNA; risk of neurotoxicity |
| Chlorambucil | Chronic lymphocytic leukaemia; oral | Milder alopecia; slower onset of action |
| Bendamustine | Lymphoma regimens | Different toxicity profile; consider renal/hepatic monitoring |
- Pros/Cons Checklist — Compare efficacy for the target disease, expected main toxicities (infertility, neurotoxicity), route (IV vs oral), and monitoring needs when discussing alternatives with specialists.
Regulation Snapshot
Cyclophosphamide is approved by Health Canada for oncologic and nephrology indications and is prescription-only.
Marketed Canadian formulations include Procytox tablets (25 mg and 50 mg) and injectable vials, as well as generics.
Products carry a Drug Identification Number (DIN); insist on recording the DIN for accurate record keeping and for provincial reimbursement claims.
Coverage and prior-authorization processes differ by province and may require special authority under Ontario Drug Benefit, BC PharmaCare, or RAMQ.
Hospitals typically source injectable cyclophosphamide through institutional procurement, while community pharmacies can fill oral prescriptions following hazardous drug handling rules.
- Approval Paperwork Checklist — Ensure prescription includes indication, dosage, and verify DIN for processing with provincial plans.
FAQ
Will Cytoxan Make Me Infertile?
Sterility is a known risk, and the likelihood rises with higher cumulative doses and certain regimens, particularly in men.
Discuss fertility preservation options such as sperm banking or oocyte/embryo preservation before starting treatment.
Can I Get Cytoxan At My Local Shoppers Or Jean Coutu?
Oral tablets are often dispensed by community pharmacies with a valid prescription and DIN; injectable forms are typically prepared in hospital pharmacies or infusion centres, so call ahead.
How Long After Stopping Should I Avoid Pregnancy?
Follow specialist guidance; many protocols require contraception during treatment and for a specified period afterwards, with timelines documented in the patient chart.
What If I Miss A Dose?
If an oral dose is missed, take it as soon as remembered unless the next dose is near; never double up doses and contact your care team for instructions about IV schedule changes.
- Immediate Actions Checklist — Missed dose: follow the above rule; Spill/exposure: isolate area, call poison control, follow institutional spill protocol; Severe reaction: go to emergency department and bring DIN information.
Guidelines For Proper Use
Follow the Health Canada product monograph and institutional protocols when using cyclophosphamide.
Pharmacists should confirm the DIN, counsel on side effects, provide written instructions, and advise on safe handling and disposal.
Baseline labs typically include CBC, creatinine, and liver function tests, with pregnancy testing for people of reproductive potential.
Monitoring frequency depends on regimen intensity and may include CBC weekly during high-intensity cycles.
Support services include pharmacist medication reviews, provincial cancer patient navigation, and fertility counselling referral pathways.
| Test | Typical Frequency |
|---|---|
| CBC (Complete Blood Count) | Baseline and periodically during therapy; frequency varies by regimen (often weekly or before each cycle) |
| Creatinine / Renal Function | Baseline and periodically; more frequent if renal impairment exists |
| Liver Function Tests | Baseline and periodically during therapy |
- Pharmacist Counselling Checklist — Confirm DIN, review side effects and contraception advice, explain hydration and MESNA if ordered, provide written instructions and local contact numbers.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-9 days |
| London | Ontario | 5-9 days |
| Hamilton | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
Final Notes
Keep the DIN from your medication packaging in your records and show it to your pharmacist for every refill or prior-authorization request.
Discuss fertility preservation early if you are of reproductive potential, because sterility can occur with cumulative exposure.
If you notice signs of infection, severe bleeding, or new urinary symptoms, contact your care team or go to the emergency department without delay.
When arranging supply, call ahead to community pharmacies or hospital pharmacies to confirm stock and required paperwork.
Always follow the product monograph and your specialist’s instructions for dose, monitoring, and handling of cyclophosphamide tablets or injection.